Goldman Sachs target China’s CSI300 to 4800
- had previously set their target at 4500
GS says China is evolving from “reopening” to a wider “growth recovery” theme
—
UBS also, says “we continue to hold a positive view on the China market”, citing:
- herd immunity occurring faster than expected
- undemanding valuations
- policy support likely to provide a backstop for growth